Propanc Biopharma (PPCB) Goodwill & Intangibles (2011 - 2012)

Propanc Biopharma (PPCB) posted quarterly Goodwill & Intangibles of $27016.0 for Q1 2012, up 2.07% quarter-over-quarter from $26468.0 in Q4 2011.

Propanc Biopharma (PPCB) Goodwill & Intangibles (2011 - 2012) Analysis & Trends

Propanc Biopharma (PPCB) has reported Goodwill & Intangibles for 2 consecutive years, with $27016.0 the latest figure, recorded in Q1 2012.

In Q1 2012, Goodwill & Intangibles changed N/A year-over-year to $27016.0; the TTM figure through Mar 2012 stood at $27016.0 (changed N/A YoY), while the FY2011 annual figure was $27563.0, changed N/A from the prior year.
Goodwill & Intangibles climbed to $27016.0 in Q1 2012 per PPCB's latest filing, from $26468.0 in the prior quarter.
Across five years, Goodwill & Intangibles topped out at $27563.0 in Q2 2011 and bottomed at $26468.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Propanc Biopharma	587,855.41	587,855.41	-

Download Data